Technology
Health
Pharmaceutical
Arcus Biosciences
$8.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$8.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.08 (0.95%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours
Why Robinhood?
You can buy or sell RCUS and other stocks, options, ETFs, and crypto commission-free!
About RCUS
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. Read More The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Employees
108
Headquarters
Hayward, California
Founded
2015
Market Cap
376.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
111.17K
High Today
$8.59
Low Today
$8.40
Open Price
$8.40
Volume
47.82K
52 Week High
$16.06
52 Week Low
$7.15
Collections
Technology
Health
Pharmaceutical
Biotechnology
Cancer Prevention
2018 IPO
US
North America
Price Paid on Robinhood
25% Lower
Right Now
52 Week Low
$7.15
Average Price Paid
$11.36
52 Week High
$16.06
RCUS Earnings
-$1.37
-$1.00
-$0.62
-$0.25
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 5, Pre-Market